301 related articles for article (PubMed ID: 28476751)
41. Characterization of Multiple Cytokine Combinations and TGF-β on Differentiation and Functions of Myeloid-Derived Suppressor Cells.
Lee CR; Lee W; Cho SK; Park SG
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29543758
[TBL] [Abstract][Full Text] [Related]
42. Effect of mild hypothermia on the increase of CD11b+ Gr-1+ myeloid-derived suppressor cells induced by lipopolysaccharide in a mouse model of sepsis.
Li X; Liu L; Luo F; Gui L; Fan D; Xie Q
Am J Emerg Med; 2015 Oct; 33(10):1430-5. PubMed ID: 26275630
[TBL] [Abstract][Full Text] [Related]
43. [Recombinant HMGB1 induces the differentiation of mouse myeloid cells into myeloid-derived suppressor cells in vitro].
Su Z; Zhang Y; Ni P; Wang J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Oct; 32(10):1362-1365. PubMed ID: 27667463
[TBL] [Abstract][Full Text] [Related]
44. A Novel CD48-Based Analysis of Sepsis-Induced Mouse Myeloid-Derived Suppressor Cell Compartments.
Jia B; Zhao C; Li G; Kong Y; Ma Y; Wang Q; Wang B; Zeng H
Mediators Inflamm; 2017; 2017():7521701. PubMed ID: 28337051
[TBL] [Abstract][Full Text] [Related]
45. Myeloid-specific expression of human lysosomal acid lipase corrects malformation and malfunction of myeloid-derived suppressor cells in lal-/- mice.
Qu P; Yan C; Blum JS; Kapur R; Du H
J Immunol; 2011 Oct; 187(7):3854-66. PubMed ID: 21900179
[TBL] [Abstract][Full Text] [Related]
46. Co-delivery of RNAi and chemokine by polyarginine nanocapsules enables the modulation of myeloid-derived suppressor cells.
Ledo AM; Sasso MS; Bronte V; Marigo I; Boyd BJ; Garcia-Fuentes M; Alonso MJ
J Control Release; 2019 Feb; 295():60-73. PubMed ID: 30593832
[TBL] [Abstract][Full Text] [Related]
47. mTOR signaling disruption from myeloid-derived suppressive cells protects against immune-mediated hepatic injury through the HIF1α-dependent glycolytic pathway.
Chen X; Zhang Z; Bi Y; Fu Z; Gong P; Li Y; Yu Q; Jia A; Wang J; Xue L; Yang H; Liu G
J Leukoc Biol; 2016 Dec; 100(6):1349-1362. PubMed ID: 27462101
[TBL] [Abstract][Full Text] [Related]
48. IL-7 treatment augments and prolongs sepsis-induced expansion of IL-10-producing B lymphocytes and myeloid-derived suppressor cells.
Kulkarni U; Herrmenau C; Win SJ; Bauer M; Kamradt T
PLoS One; 2018; 13(2):e0192304. PubMed ID: 29466409
[TBL] [Abstract][Full Text] [Related]
49. C/EBPβ is involved in the amplification of early granulocyte precursors during candidemia-induced "emergency" granulopoiesis.
Satake S; Hirai H; Hayashi Y; Shime N; Tamura A; Yao H; Yoshioka S; Miura Y; Inaba T; Fujita N; Ashihara E; Imanishi J; Sawa T; Maekawa T
J Immunol; 2012 Nov; 189(9):4546-55. PubMed ID: 23024276
[TBL] [Abstract][Full Text] [Related]
50. Blockade of Cycloxygenase-2 ameliorates sepsis induced immune-suppression by regulating myeloid-derived suppressor cells.
Chen J; Cai S; Li R; Xie J; Yang F; Liu T
Int Immunopharmacol; 2022 Mar; 104():108506. PubMed ID: 35008007
[TBL] [Abstract][Full Text] [Related]
51. Tristetraprolin limits age-related expansion of myeloid-derived suppressor cells.
Kwack KH; Zhang L; Kramer ED; Thiyagarajan R; Lamb NA; Arao Y; Bard JE; Seldeen KL; Troen BR; Blackshear PJ; Abrams SI; Kirkwood KL
Front Immunol; 2022; 13():1002163. PubMed ID: 36263047
[TBL] [Abstract][Full Text] [Related]
52. The Granulocyte Progenitor Stage Is a Key Target of IRF8-Mediated Regulation of Myeloid-Derived Suppressor Cell Production.
Netherby CS; Messmer MN; Burkard-Mandel L; Colligan S; Miller A; Cortes Gomez E; Wang J; Nemeth MJ; Abrams SI
J Immunol; 2017 May; 198(10):4129-4139. PubMed ID: 28356386
[TBL] [Abstract][Full Text] [Related]
53. Potential role of myeloid-derived suppressor cells in transition from reaction to repair phase of bone healing process.
Kawai H; Oo MW; Tsujigiwa H; Nakano K; Takabatake K; Sukegawa S; Nagatsuka H
Int J Med Sci; 2021; 18(8):1824-1830. PubMed ID: 33746599
[TBL] [Abstract][Full Text] [Related]
54. C-Reactive Protein Promotes the Expansion of Myeloid Derived Cells With Suppressor Functions.
Jimenez RV; Kuznetsova V; Connelly AN; Hel Z; Szalai AJ
Front Immunol; 2019; 10():2183. PubMed ID: 31620123
[TBL] [Abstract][Full Text] [Related]
55. CCAAT/Enhancer-binding protein β promotes pathogenesis of EAE.
Simpson-Abelson MR; Hernandez-Mir G; Childs EE; Cruz JA; Poholek AC; Chattopadhyay A; Gaffen SL; McGeachy MJ
Cytokine; 2017 Apr; 92():24-32. PubMed ID: 28088614
[TBL] [Abstract][Full Text] [Related]
56. All-trans-retinoic acid restores CD4+ T cell response after sepsis by inhibiting the expansion and activation of myeloid-derived suppressor cells.
Liu T; Yang F; Xie J; Chen J; Gao W; Bai X; Li Z
Mol Immunol; 2021 Aug; 136():8-15. PubMed ID: 34051632
[TBL] [Abstract][Full Text] [Related]
57. SETD1B Activates iNOS Expression in Myeloid-Derived Suppressor Cells.
Redd PS; Ibrahim ML; Klement JD; Sharman SK; Paschall AV; Yang D; Nayak-Kapoor A; Liu K
Cancer Res; 2017 Jun; 77(11):2834-2843. PubMed ID: 28381543
[TBL] [Abstract][Full Text] [Related]
58. MiR-30a increases MDSC differentiation and immunosuppressive function by targeting SOCS3 in mice with B-cell lymphoma.
Xu Z; Ji J; Xu J; Li D; Shi G; Liu F; Ding L; Ren J; Dou H; Wang T; Hou Y
FEBS J; 2017 Aug; 284(15):2410-2424. PubMed ID: 28605567
[TBL] [Abstract][Full Text] [Related]
59. Myeloid-derived suppressor cell functionality and interaction with Leishmania major parasites differ in C57BL/6 and BALB/c mice.
Schmid M; Zimara N; Wege AK; Ritter U
Eur J Immunol; 2014 Nov; 44(11):3295-306. PubMed ID: 25142017
[TBL] [Abstract][Full Text] [Related]
60. Neonatal myeloid derived suppressor cells show reduced apoptosis and immunosuppressive activity upon infection with Escherichia coli.
Leiber A; Schwarz J; Köstlin N; Spring B; Fehrenbach B; Katava N; Poets CF; Gille C
Eur J Immunol; 2017 Jun; 47(6):1009-1021. PubMed ID: 28493377
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
